Posted by Michael Wonder on 30 Mar 2020
U.S. regulator approves limited use of malaria drugs for COVID-19
30 March 2020 - A limited emergency-use authorisation for two antimalarial drugs touted as game-changers by President Donald Trump has been issued by the U.S. FDA to treat coronavirus patients.
In a statement published Sunday, the U.S. Department of Health and Human Services detailed recent donations of medicine to a national stockpile -- including chloroquine and hydroxychloroquine, both being investigated as potential COVID-19 treatments.
It said the FDA had allowed them "to be distributed and prescribed by doctors to hospitalised teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible."
